New Delhi-based Glenmark's USFDA-approved 15 mg and 25 mg Topiramate capsules, equivalent to Janssen's Topamax, will be marketed by Glenmar...

"Treatment of obesity to achieve a sustained loss of 15 per cent body weight has been shown to have a major impact on type 2 diabetes progr...

Glenmark Pharmaceuticals Ltd has received final approval from the United States Food and Drug Administration (USFDA) for Topiramate extende...

Zydus Cadila has more than 170 approvals and has so far filed over 310 abbreviated new drug applications (ANDAs) since it commenced filings...

Cadila Healthcare have finalised an agreement with Supernus Pharmaceuticals Inc to settle all outstanding patent litigation.

The lender would release the fund in tranches as the projects near completion. Piramal Fund's managing director, Khusru Jijina, confirmed s...

ET Now spoke to dealers on institutional and HNI's activity in the dealing room. The following stocks were on their radar on unconfirmed re...

Glenmark Generics is recalling multiple lots of three of its drugs from the US market due to "odd smell", according to US FDA.

Pharma firm Ranbaxy on Monday said it has received US regulatory approval for Topiramate tablets, used in the treatment of epilepsy.

Oil prices fell in Asian trade after global equity markets showed signs of weariness after a pull-back rally.

Sun Pharma today said the US Food and Drug Administration (FDA) has granted an approval for its abbreviated new drug application to market ...

Sun Pharma said US health regulator Food and Drug Administration has approved its Abbreviated New Drug Application (ANDA) to market generic...

Glenmark Pharmaceuticals says it has received the USFDA tentative approval to market Topiramate tablets.

Cadila Healthcare today said it has received tentative USFDA approval for Topiramate Tablets, an anti-epileptic drug in multiple strengths.